- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07926529
The Effect of Laughter Therapy on the Quality of Life and Psychological Well-being of Nursing Students
The nursing profession is a healthcare discipline that combines theoretical knowledge with clinical practice skills. The primary aim of nursing education is to train healthcare professionals who are prepared for the profession, aware of their duties and responsibilities, and capable of providing effective care to individuals and the community. During their education, nursing students face various challenges both in the academic sphere and in clinical settings. Students are confronted with numerous stressors, such as a heavy course load, preparing for examinations, undertaking clinical placements, a lack of self-confidence, and the changes brought about by the university environment. When this process is not managed effectively, it is thought that students' quality of life and psychological well-being may be adversely affected. Accordingly, there is a need for complementary health approaches to enhance nursing students' quality of life and to safeguard and promote their psychological well-being. Included among these complementary health approaches, laughter therapy has physiological and psychological effects on individuals. There are numerous positive effects associated with laughter, such as improving cognitive functions, enhancing respiration, increasing pain tolerance, improving sleep quality, reducing exam anxiety and lowering stress hormone levels.
Accordingly, the aim of this thesis is to investigate the effect of laughter therapy administered to nursing students on their quality of life and psychological well-being. A review of the literature revealed no existing studies on this topic. Consequently, it is anticipated that this planned thesis will make a significant contribution to filling this gap in the literature.
The study is planned as a randomised controlled experimental study using a pre-test-post-test-follow-up design. The research will be conducted with second-year nursing students at the Faculty of Health Sciences, Çankırı Karatekin University. A total of 112 students who meet the inclusion criteria and are allocated to the experimental (n=56) and control (n=56) groups via randomisation will form the study sample. Experimental group students will undergo a laughter therapy programme comprising a total of eight sessions, at a rate of two sessions per week; the control group will receive no intervention during the study period. Session times will be planned together with the students in the experimental group who will receive laughter therapy. Research data will be collected using the Demographic Information Form, the SF-12 Quality of Life Scale and the Psychological Well-being Scale. IBM SPSS Statistics for Windows, Version 24.0, will be used to analyse the data obtained from this study.
Panoramica dello studio
Stato
Intervento / Trattamento
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: fahriye s kara
- Numero di telefono: +90 539 210 49 71
- Email: 248426003@ogrenci.karatekin.edu.tr
Luoghi di studio
-
-
Çankırı
-
Çankırı, Çankırı, Turchia (Türkiye)
- Cankiri Kaatekin University
-
Contatto:
- fahriye s kara
- Numero di telefono: +90 539 210 49 71
- Email: 248426003@ogrenci.karaetin.edu.tr
-
Investigatore principale:
- fahriye s kara
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
- Adulto più anziano
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Be a second-year nursing student in the Department of Nursing at Çankırı Karatekin University
- Be able to speak and understand Turkish
- Have no diagnosed psychiatric disorders
- Have no communication difficulties
- Agree to participate in laughter therapy sessions
- Have no history of using psychotropic medications, either currently or in the past
Exclusion Criteria:
- Failure to attend all laughter therapy sessions
- Having a physical condition that would prevent participation in laughter therapy sessions
- Having previously participated in laughter therapy
- Using medication or another nonpharmacological method to reduce stress
- Having difficulty performing breathing exercises
- Not volunteering to participate in the study
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Nessun intervento: Gruppo di Controllo senza Intervento
|
|
|
Sperimentale: Laughter Therapy Group
|
Experimental group students will undergo a laughter therapy programme comprising a total of eight sessions, at a rate of two sessions per week; the control group will receive no intervention during the study period. The days and times for the laughter therapy sessions to be conducted with the experimental group will be planned in consultation with the students. The sessions will be held in a suitable classroom or conference room with the participants seated in a U-shaped arrangement. During the first session, students will receive a brief introduction and information about the activities to be conducted throughout the session. Each session aims to encourage spontaneous laughter by incorporating breathing exercises, rhythmic clapping and vocal exercises, playful and energetic games, "icebreaker laughter," and guided meditation. Each session is scheduled to last approximately 40 minutes. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in quality of life measured by the 12-item Quality of Life Scale
Lasso di tempo: Baseline (before the intervention) and immediately after completion of the intervention
|
The scale was developed by Ware et al. in 1995. A validity and reliability study conducted by Soylu and Kütük in 2002 demonstrated that it is a measurement tool with adequate psychometric properties for assessing general health status and health-related quality of life in clinical practice and scientific research. The scale comprises 12 items across eight sub-dimensions: physical functioning (2 items), physical role (2 items), bodily pain (1 item), general health (1 item), energy (1 item), social functioning (1 item), emotional role (2 items) and mental health (2 items). Items relating to physical and emotional roles are answered on a dichotomous basis (yes or no), whilst the other items are measured on a Likert scale ranging from 3 to 6. A score of 100 on the scale indicates the best state of health, whilst a score of 0 indicates the worst state of health. In the Turkish validity and reliability study, the Cronbach's alpha coefficient was determined to be between 0.92 and 0.88. |
Baseline (before the intervention) and immediately after completion of the intervention
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in psychological well-being measued by the 8-item Psychological Well-being Scale
Lasso di tempo: Baseline (before the intervention) and immediately after completion of the intervention
|
The scale identifies key elements of human functioning, ranging from positive relationships to feelings of competence and leading a meaningful and purposeful life. It was developed by Diener and colleagues in 2009. The adaptation into Turkish was carried out by Telef in 2011. In the reliability study of the scale, the Cronbach's alpha internal consistency coefficient was calculated as .80 The items on the Psychological Well-being Scale are rated on a scale of 1 to 7, ranging from 'I strongly disagree' (1) to 'I strongly agree' (7). All items are phrased in positive terms. Scores range from 8 to 56. A high score indicates that the individual possesses a wide range of psychological resources and strengths. Although the scale does not provide separate measurements of the various dimensions of well-being, it offers a general overview of positive functioning across different areas that we believe to be important. |
Baseline (before the intervention) and immediately after completion of the intervention
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: fahriye s kara, Çankırı Karatekin University
- Direttore dello studio: mevlut karatas, professor, Çankırı Karatekin University
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- ÇAKÜ-SB-2026-0051
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .